Method for treating motor-autonomic disorders in children

FIELD: medicine, pediatrics.

SUBSTANCE: the present innovation deals with treating motor-autonomic disorders in children associated with affected function of central nervous system. For this purpose one should puncture perineural areas in the region of the main nervous trunks with alfetin dissolved in cerebrolysine. Additionally, one should puncture in projection area of cervical and lumbar spinal thickenings and areas that correspond to segmentary innervation of organs with affected function and, also, in scalp areas depending upon the character of patient's disorders. The method suggested provides improved autonomic-trophic impact of nervous system.

EFFECT: higher efficiency of therapy.

2 ex

 

The invention relates to medicine, namely to Pediatrics, and can be used for the treatment of motor and autonomic disorders in children, associated with deficient function of the Central nervous system.

There is a method of treatment of disorders of motor development in children, including around the Cerebrolysin in microdoses okolonauchnyh zones in the area of main nerve trunks and additional chip scleroderma and miernyk zones Cerebrolysin in combination with galantamine, sodium oxybutyrate, lidazoy and proserin, and the last choice of drugs is carried out in accordance with the nature of the violations. Depending on the location and forms of musculoskeletal disorders on one session of injections varies from 10 to 100 and more points of microinjection. Along with perineurally the chip enter microdose of Cerebrolysin in Sclerotinia zone: the periosteum of the clavicle, scapula, powszechnie bones and tendons, and also impose microdose sodium oxybutyrate in nomernye zone spastic muscles of the upper and lower extremities (A.S. No. 2020955, may 1992, “a Method of treatment of disorders of motor development in children”).

The disadvantage of this method is the large number of painful injections, causing the child pain stress (around 100 points miernyk, scleroderma and neuraminic zones with a syringe) temporary effect from symptomatic drugs (galantamine, neostigmine, sodium oxybutyrate) and the absence of their trophic effect on the nerve cell in the proposed areas of introduction. Also skipped around the projection of the main areas of the nervous system, through which the implementation of a pathological motor or motor-autonomic act. We are talking about areas of the projection of the cervical and lumbar thickening of the spinal cord, as well as areas of the scalp that are anatomical projections of the structures of the brain responsible for certain functions of organs and systems. The disadvantage of the existing method is also something that is not made around the areas of projection of segmental innervation of the organ with impaired function, and used for treatment only partially can change the function of nerve cells, not as immunomodulators and supervisors the correct implementation of the genetic program.

Task to be solved by the claimed invention is directed, is the creation of effective treatment of motor and autonomic disorders in children.

The technical result of the invention is to improve the treatment efficiency of the motor and autonomic disorders in children due to the choice of the most effective medicines, carrying out a comprehensive regulatory function in the body and using the Oia optimal therapeutic areas.

This technical result in the implementation of the invention is achieved in that in the known method for the treatment of motor and autonomic disorders in children, including chip in microdoses okolonauchnyh zones in the area of main nerve trunks, around the produce embryonic protein alpha-fetoprotein (drug Alpechin)dissolved in Cerebrolysin, optionally in the area of projection of the cervical and lumbar thickening of the spinal cord and areas corresponding to the segmental innervation of organs with impaired function, as well as to areas of the scalp, depending on the nature of the disorders in a patient.

Conducted by the applicant's analysis of the prior art, including searching by the patent and scientific and technical information sources has allowed to establish that the proposed method is not known and should not be explicitly studied the prior art, i.e. meets the criteria of “novelty” and “inventive step”.

The proposed method can be applied in any of the children's departments dealing with the problem of treating neurological and neurosomatic disorders in children.

Thus, the inventive method is available and, therefore, practically applicable.

The proposed method is a combination of therapeutic approaches to provide highly effective the th treatment of motor and autonomic disorders in children, by choosing the optimal therapeutic areas and use of embryonic protein alpha-fetoprotein (preparation of Alpechin)dissolved in Cerebrolysin.

The method is as follows:

A child with motor-vegetatively violations carried out chip in microdoses okolonauchnyh zones in the area of main nerve trunks embryonic protein alpha-fetoprotein (drug Alpechin)dissolved in Cerebrolysin, in the area of projection of the cervical and lumbar thickening of the spinal cord and in the zones corresponding to the segmental innervation of organs with impaired function, as well as to areas of the scalp, depending on the nature of the disorders in a patient (Ndistance. Reflexology. The Handbook. Kishinev, 1987. - s-313), using from 5 to 10 points per procedure.

The number of treatments varies from 5 to 10 depending on the appearance desired effect.

Example 1.

Patient K. 6 months was admitted with a diagnosis of Perinatal lesions of the Central nervous system, birth trauma cervical spine subluxation in atlantoaxial joint and unstable dorsal dislocation of C3-C4 vertebrae, mixed paresis of the upper extremities and pyramidal deficit in the lower extremities, the syndrome of intracranial hypertension, syndrome of vegetative-trophic disorders with hemihypertrophy limb is her on the left and their temperature hypothermia (0,8° C), impaired intestinal motility with his atony, subcompensated dysbacteriosis of the intestine.

The child was also diagnosed with the lagging motor development. The baby does not roll over, hold his head uncertainly, grabbing toys left hand is limited due to paresis, hypomimia, observed symptom marble skin, more pronounced on the left side, frequent vomiting and stool retention.

Conducted therapy alfedena: session 75 µg and 2 ml Cerebrolysin on session 7 session. Conducted introduction of alfedena with Cerebrolysin in zone No. 5 scalp area (intestine) (Ndistance. Reflexology. The Handbook. Kishinev. 1987. - s-313), the area of projection of the cervical (segments of spinal cord C5-C8) and lumbar (L1-S2) thickening, 1 injection and projection zones of major nerve trunks and with paravertebral thoracic to sacral spine.

After the treatment course (7 sessions in a day), the baby developed a full-fledged movement in the upper limbs, it was good to take toys with the left hand, be confident to keep your head, began to roll over, trying to get up from a lying position to a sitting position, there was a good visual and auditory focus with the emergence of emotional facial expressions, almost stopped vomiting and normalized regular chair. When conducting computer imaging from the echino sharp decrease hypothermia left limb is almost normal (temperature gradient of 0.4° C).

Example 2.

Patient M 14 years. Diagnosis: Vegetative-vascular dystonia, mixed type, paroxysmal-permanent for headache busy type, cardialgia. Complaints of a headache and pressing character in the occipital-parietal region, often after exhaustion, cold to the touch, numbness, and increased sweating of palms and feet, stabbing pain in the heart, lomadia pain in the lower extremities more often at night. When conducting computer imaging has terminatria feet and hands.

Conducted 3 sessions in a day in this procedure:

used areas of the scalp No. 2, No. 8; No. 11; main nerve trunks limbs; paravertebral level C3-L5.

During the week after the session sharply decreased sweating, and numbness of the feet, hands, limbs become warm to the touch, stopped headaches, pain in the heart and the pain in his legs, feeling good. In routine imaging studies, the appearance of thermal figure 4 fingers on the left and 3 fingers on the right, and the emergence of thermal pattern on the feet with temperature gradient of 0.5 degrees (hypothermia on the right).

Thus, improving vegetative trophic influence of the nervous system is confirmed by clinical improvement, but will put the school dynamics by computer imaging study.

According to this method, the treatment of 29 children. All marked positive effect, occurring in the course of treatment.

A method for the treatment of motor and autonomic disorders in children, including around the Cerebrolysin okolonauchnyh zones in the area of main nerve trunks, characterized in that the chip produced by Aleftina dissolved in Cerebrolysin, additionally carry around in the field of projection of the cervical and lumbar thickening of the spinal cord and in the zones corresponding to the segmental innervation of organs with impaired function, as well as to areas of the scalp, depending on the nature of the disorders in a patient.



 

Same patents:
The invention relates to medicine, in particular to endocrinology, and for the treatment of complications of diabetes - neuropathy

The invention relates to medicine, in particular for orthopedics and neurosurgery, vertebrology, and can be used in the intervertebral disc

The invention relates to medicine and can be used in the treatment of musculoskeletal disorders of the larynx caused by damage to the recurrent nerve

The invention relates to pharmaceutical industry and relates to a therapeutic agent for the treatment of stenosis of the spinal canal, comprising 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(3-pyridylmethylamine)-3(2H)-pyridazinone effective amount of the agent has a high activity
The invention relates to medicine, in particular to orthopedics, and can be used for the treatment of lumbar degenerative disc disease

The invention relates to a derivative of L-arginine, method for their production and pharmaceutical compositions based on them

The invention relates to medicine, in particular for neurology and relates to the application benzenepropanoic derivatives for the treatment of peripheral neuropathic conditions, neurodegenerative diseases of the Central nervous system and autoimmune diseases of the nervous system
The invention relates to medicine, in particular to neuralgia, and for the treatment of multiple sclerosis
The invention relates to the field of treatment of acute CNS, and in particular to methods of treatment OSPS in children, and can be used in clinical practice

The invention relates to the medical industry and relates to immunomodulatory agent "BOLETIM", method of its production and its injectable form

The invention relates to medicine and relates to inhibitors for use in hemostasis and immune response
The invention relates to medicine, in particular to anesthesiology and critical care medicine, and may find application in the treatment of injuries of the respiratory system by inhalation

The invention relates to the field of biotechnology, specifically to means of stimulating preparirovanie damage cells, and may be used in therapy and cosmetology

The invention relates to the field of biotechnology and can be used in medicine

The invention relates to medicine and relates to peptides that can be used for cell adhesion and wound healing

The invention relates to new peptides having the amino acid sequence of the 9-55 amino acid residues, comprising the amino acid sequence FTLASAETT (SEQ ID NO:l), pharmaceutical compositions for treatment of autoimmune diseases, containing one or more of these peptides and a pharmaceutically acceptable carrier
The invention relates to medicine, namely to ENT surgery
Up!